Opposing Effects of NGF and proNGF on HIV Induced Macrophage Activation

Journal of Neuroimmune Pharmacology

Volumn 11, Issue 1, 2016, Pages 98-120

  Williams, Kimberly S ^a,b   Killebrew, Deirdre A ^a,c   Clary, Gillian P ^a,d   Meeker, Rick B ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Actin; Calcium; Inflammation; Neuroprotection; p75 neurotrophin receptor; TrkA

Indexed keywords

ANGIOSTATIN; CALCIUM; FIBROBLAST GROWTH FACTOR 9; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; NERVE GROWTH FACTOR; NEUROTOXIN; NEUROTROPHIN; NEUROTROPHIN RECEPTOR P75; NEUTRALIZING ANTIBODY; PRO NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; CONDITIONED MEDIUM;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COGNITION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE ACTIVATION; NEUROTOXICITY; NONHUMAN; PHAGOCYTOSIS; PODOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL CULTURE; CONDITIONED MEDIUM; HUMAN; LONG EVANS RAT; MACROPHAGE; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE ACTIVATION; MACROPHAGES; NERVE GROWTH FACTOR; RATS; RATS, LONG-EVANS;

EID: 84957430700     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-015-9631-z     Document Type: Article

References (56)

1. Al-Shawi R, Hafner A, Chun S, Raza S, Crutcher K, Thrasivoulou C, Simons P, Cowen T (2007) ProNGF, sortilin, and age-related neurodegeneration. Ann N Y Acad Sci 1119:208–215
2. Belrose JC, Masoudi R, Michalski B, Fahnestock M (2014) Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer’s disease tauopathies. Neurobiol Aging 35:926–933
3. Bruno MA, Cuello AC (2006) Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci U S A 103:6735–6740
4. Burger KL, Davis AL, Isom S, Mishra N, Seals DF (2011) The podosome marker protein Tks5 regulates macrophage invasive behavior. Cytoskeleton (Hoboken) 68:694–711
5. Caporali A, Pani E, Horrevoets AJ, Kraenkel N, Oikawa A, Sala-Newby GB, Meloni M, Cristofaro B, Graiani G, Leroyer AS, Boulanger CM, Spinetti G, Yoon SO, Madeddu P, Emanueli C (2008) Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res 103:e15–26
6. Capsoni S, Brandi R, Arisi I, D’Onofrio M, Cattaneo A (2011) A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer’s disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol Disord Drug Targets 10:635–647
7. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46:391–398
8. da Huang W, Sherman BT, Lempicki RA (2009a) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1–13
9. da Huang W, Sherman BT, Lempicki RA (2009b) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57
10. Del Corno M, Liu QH, Schols D, de Clercq E, Gessani S, Freedman BD, Collman RG (2001) HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 98:2909–2916
11. Fischer M, Dietmann A, Beer R, Broessner G, Helbok R, Pfausler B, Schmutzhard E, Lackner P (2013) Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage. PLoS One 8, e59952
12. Fischer-Smith T, Tedaldi EM, Rappaport J (2008) CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res Hum Retrovir 24:417–421
13. Garaci E, Caroleo MC, Aloe L, Aquaro S, Piacentini M, Costa N, Amendola A, Micera A, Calio R, Perno CF, Levi-Montalcini R (1999) Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci U S A 96:14013–14018
14. Giulian D, Vaca K, Noonan CA (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593–1596
15. Harrold SM, Dragic JM, Brown SL, Achim CL (2001) Neurotrophic factor regulation of human immunodeficiency virus type 1 replication in human blood-derived macrophages through modulation of coreceptor expression. Adv Exp Med Biol 493:41–47
16. Ibanez CF (2002) Jekyll-Hyde neurotrophins: the story of proNGF. Trends Neurosci 25:284–286
17. Johnston JB, Zhang K, Silva C, Shalinsky DR, Conant K, Ni W, Corbett D, Yong VW, Power C (2001) HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 49:230–241
18. Kanda T, Iwasaki T, Nakamura S, Kurokawa T, Ikeda K, Mizusawa H (2000) Self-secretion of fibroblast growth factor-9 supports basal forebrain cholinergic neurons in an autocrine/paracrine manner. Brain Res 876:22–30
19. Kaul M, Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 96:8212–8216
20. Kolson DL (2002) Neuropathogenesis of central nervous system HIV-1 infection. Clin Lab Med 22:703–717
21. Kruskal BA, Maxfield FR (1987) Cytosolic free calcium increases before and oscillates during frustrated phagocytosis in macrophages. J Cell Biol 105:2685–2693
22. Laskin DL, Sunil VR, Gardner CR, Laskin JD (2011) Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51:267–288
23. Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945–1948
24. Lee MH, Amin ND, Venkatesan A, Wang T, Tyagi R, Pant HC, Nath A (2013) Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation. J Neurovirol 19:418–431
25. Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D’Agostino C, Vullo V, Riccio P (2000) Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol 6:156–163
26. Longo FM, Yang T, Knowles JK, Xie Y, Moore LA, Massa SM (2007) Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer’s disease mechanisms. Curr Alzheimer Res 4:503–506
27. Louboutin JP, Reyes BA, Agrawal L, Van Bockstaele EJ, Strayer DS (2011) HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy. Eur J Neurosci 34:2015–2023
28. Martin S, Dicou E, Vincent JP, Mazella J (2005) Neurotensin and the neurotensin receptor-3 in microglial cells. J Neurosci Res 81:322–326
29. Meeker RB, Poulton W, Markovic-Plese S, Hall C, Robertson K (2011) Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection. J Neurovirol 17:258–273
30. Mocchetti I, Bachis A (2004) Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1/gp120-induced cell death. Crit Rev Neurobiol 16:51–57
31. Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM (2007) Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Ann N Y Acad Sci 1122:144–154
32. Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD (2007) Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res 4:340–350
33. Myers JT, Swanson JA (2002) Calcium spikes in activated macrophages during Fcgamma receptor-mediated phagocytosis. J Leukoc Biol 72:677–684
34. Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D (2008) Nerve growth factor as an angiogenic factor. Microvasc Res 75:135–141
35. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S (2000) Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 113(Pt 17):3073–3084
36. Ohsawa K, Imai Y, Sasaki Y, Kohsaka S (2004) Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 88:844–856
37. Patel PC, Harrison RE (2008) Membrane ruffles capture C3bi-opsonized particles in activated macrophages. Mol Biol Cell 19:4628–4639
38. Peng S, Wuu J, Mufson EJ, Fahnestock M (2004) Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63:641–649
39. Pulliam L, Herndier B, Tang N, McGrath M (1991a) Human immunodeficiency virus-infected macrophages produce soluable factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87:506–512
40. Pulliam L, Herndier BG, Tang NM, McGrath MS (1991b) Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87:503–512
41. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond Ser B Biol Sci 361:1545–1564
42. Rossio JL, Esser MT, Suryanarayana K, Schneider DK, Bess JW Jr, Vasquez GM, Wiltrout TA, Chertova E, Grimes MK, Sattentau Q, Arthur LO, Henderson LE, Lifson JD (1998) Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 72:7992–8001
43. Russo R, Siviglia E, Gliozzi M, Amantea D, Paoletti A, Berliocchi L, Bagetta G, Corasaniti MT (2007) Evidence implicating matrix metalloproteinases in the mechanism underlying accumulation of IL-1beta and neuronal apoptosis in the neocortex of HIV/gp120-exposed rats. Int Rev Neurobiol 82:407–421
44. Samah B, Porcheray F, Gras G (2008) Neurotrophins modulate monocyte chemotaxis without affecting macrophage function. Clin Exp Immunol 151:476–486
45. Samah B, Porcheray F, Dereuddre-Bosquet N, Gras G (2009) Nerve growth factor stimulation promotes CXCL-12 attraction of monocytes but decreases human immunodeficiency virus replication in attracted population. J Neurovirol 15:71–80
46. Shi J, Longo FM, Massa SM (2013) A small molecule p75(NTR) ligand protects neurogenesis after traumatic brain injury. Stem Cells 31:2561–2574
47. Streit WJ (2005) Microglia and neuroprotection: implications for Alzheimer’s disease. Brain Res Brain Res Rev 48:234–239
48. Taraboletti G, Benelli R, Borsotti P, Rusnati M, Presta M, Giavazzi R, Ruco L, Albini A (1999) Thrombospondin-1 inhibits Kaposi’s sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions. J Pathol 188:76–81
49. Tsai HC, Ye SY, Kunin CM, Lee SS, Wann SR, Tai MH, Shi MH, Liu YC, Chen YS (2011) Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis. Cytokine 54:109–116
50. Varon C, Tatin F, Moreau V, Van Obberghen-Schilling E, Fernandez-Sauze S, Reuzeau E, Kramer I, Genot E (2006) Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol 26:3582–3594
51. Verollet C, Souriant S, Bonnaud E, Jolicoeur P, Raynaud-Messina B, Kinnaer C, Fourquaux I, Imle A, Benichou S, Fackler OT, Poincloux R, Maridonneau-Parini I (2015) HIV-1 reprograms the migration of macrophages. Blood 125:1611–1622
52. Williams KS, Killebrew DA, Clary GP, Seawell JA, Meeker RB (2015) Differential regulation of macrophage phenotype by mature and pro-nerve growth factor. J Neuroimmunol 285:76–93
53. Wu J, Zhao D, Wu S, Wang D (2015) Ang-(1–7) exerts protective role in blood–brain barrier damage by the balance of TIMP-1/MMP-9. Eur J Pharmacol 748:30–36
54. Yang T, Knowles JK, Lu Q, Zhang H, Arancio O, Moore LA, Chang T, Wang Q, Andreasson K, Rajadas J, Fuller GG, Xie Y, Massa SM, Longo FM (2008) Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. PLoS One 3, e3604
55. Zhou F, Xue M, Qin D, Zhu X, Wang C, Zhu J, Hao T, Cheng L, Chen X, Bai Z, Feng N, Gao SJ, Lu C (2013) HIV-1 Tat promotes Kaposi’s sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3beta signaling pathway. PLoS One 8, e53145
56. Zhu X, Guo Y, Yao S, Yan Q, Xue M, Hao T, Zhou F, Zhu J, Qin D, Lu C (2014) Synergy between Kaposi’s sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene 33:1986–1996